Therapeutic Drug Monitoring in 21‐Day Oral Etoposide Treatment for Lung Cancer

We aimed to determine whether or not therapeutic drug monitoring is applicable to 21‐day oral etoposide treatment for lung cancer. As the starting dose, a 25‐mg capsule of etoposide was taken orally three times daily (75 mg/body). To achieve the target concentration range of 1.0 to 1.5 μg/ml, the do...

Descripción completa

Detalles Bibliográficos
Autores principales: Ando, Yuichi, Minami, Hironobu, Saka, Hideo, Ando, Masahiko, Sakai, Shuzo, Shimokata, Kaoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1996
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921180/
https://www.ncbi.nlm.nih.gov/pubmed/8797893
http://dx.doi.org/10.1111/j.1349-7006.1996.tb02111.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921180/
https://www.ncbi.nlm.nih.gov/pubmed/8797893
http://dx.doi.org/10.1111/j.1349-7006.1996.tb02111.x

Ejemplares similares